This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alkhateeb A, Fain PR, Thody A et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208–214
Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920
Berger TG, Kiesewetter F, Maczek C et al (2006) Psoriasis confined strictly to vitiligo areas—a Koebner-like phenomenon? J Eur Acad Dermatol Venereol 20:178–183
Boisseau-Garsaud AM, Garsaud P, Calès-Quist D et al (2000) Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol 39:18–20
Boissy RE, Manga P (2004) On the etiology of contact/ occupational vitiligo. Pigment Cell Res 17:208–214
Brandrup F, Holm N, Grunnet N et al (1982) Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 62:229–236
Cario-André M, Ardilouze L, Pain C et al (2006) Imatinib mesilate inhibits melanogenesis in vitro. Br J Dermatol 155:493–494
Das SK, Majumder PP, Chakraborty R et al (1985) Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 2:71–78
Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29:428–434
De Vijlder HC, Westerhof W, Schreuder GM et al (2004) Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 17:270–274
Gauthier Y, Cario-Andre M, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16:322–332
Gogas H, Ioannovich J, Dafni U et al (2006) Prognostic sig-nificance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354:709–718
Guillet G, Helenon R, Gauthier Y et al (1988) Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation. J Cutan Pathol 15:286–289
Hann SK, Lee HJ (1996) Segmental vitiligo: clinical find-ings in 208 patients. J Am Acad Dermatol 35:671–674
Hartmann A, Bedenk C, Keikavoussi P et al (2008) Vitiligo and melanoma-associated hypopigmentation (MAH):shared and discriminative features. J Dtsch Dermatol Ges 6:1053–1059
Howitz J, Brodthagen H, Schwartz M et al (1977) Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 113:47–52
Kim YC, Kim YJ, Kang HY et al (2008) Histopathologic features in vitiligo. Am J Dermatopathol 30:112–116
Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97:255–261
Kumarasinghe SP, Tan SH, Thng S et al (2006) Progressive macular hypomelanosis in Singapore: a clinico-pathological study. Int J Dermatol 45:737–742
Lee HS, Chun YS, Hann SK (1999) Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol 40:21–26
Liu JB, Li M, Yang S et al (2005) Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327–331
Mashiah J, Brenner S (2008) Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imi-quimod. Clin Exp Dermatol 33:74–76
Mulekar SV, Al Issa A, Asaad M et al (2006) Mixed vitiligo. J Cutan Med Surg 10:104–107
Oplatek A, Brown K, Sen S, et al (2006) Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res 27:26–33
Relyveld GN, Dingemans KP, Menke HE et al (2008) Ultrastructural findings in progressive macular hypomelano-sis indicate decreased melanin production. J Eur Acad Dermatol Venereol 22:568–574
Schallreuter KU, Krüger C, Rokos H et al (2007) Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo. Arch Dermatol Res 299:225–230
Schallreuter KU, Krüger C, Würfel BA et al (2008) From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol 47:743–753
Schultz Larsen F (1993) Atopic dermatitis: a genetic-epide-miologic study in a population-based twin sample. J Am Acad Dermatol 28:719–723
Sehgal VN, Srivastava G (2007) Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol 73:149–156
Singh M, Singh G, Kanwar AJ, Belhaj MS (1985) Clinical pattern of vitiligo in Libya. Int J Dermatol 24:233–235
Singh ZN, Tretiakova MS, Shea CR, Petronic-Rosic VM (2006) Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol 19:1255–1260
Smith DA, Burgdorf WH (1984) Universal cutaneous depig-mentation following phenytoin-induced toxic epidermal necrolysis. J Am Acad Dermatol 10:106–109
Spritz RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20:271–278
Taïeb A, Picardo M; VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27–35
Thoma W, Krämer HJ, Mayser P (2005) Pityriasis versicolor alba. J Eur Acad Dermatol Venereol 19:147–152
Westerhof W, Relyveld GN, Kingswijk MM et al (2004) Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol 140:210–214
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Taïeb, A., Picardo, M. (2010). Epidemiology, Definitions and Classification. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69361-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-69361-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69360-4
Online ISBN: 978-3-540-69361-1
eBook Packages: MedicineMedicine (R0)